- Home
- Free Tools
- GLP-1 Dosing Calendar Generator
Free GLP-1 tool
GLP-1 Dosing Calendar Generator
Organize injection dates. The calendar never decides that you are ready to increase.
What this result means
Build a weekly calendar from the labeled reference schedule or stay on the clinician-directed dose.
Reminder dates stay at the clinician-directed dose you enter. Label reference lists minimum intervals and labeled options only. The calendar never assigns a future increase because a date arrived.
What this tool cannot tell you
- That you are ready to move to a higher dose.
- What to do after a missed dose — use the missed-dose planner.
- Whether a labeled step matches your prescription.
Methodology & sources
Reminder dates stay at the clinician-directed dose you enter. Label reference lists minimum intervals and labeled options only. The calendar never assigns a future increase because a date arrived.
- WEGOVY (semaglutide) injection / tablet prescribing information
U.S. National Library of Medicine DailyMed / Novo Nordisk · 2026-06 · Last verified 2026-09-16
Used for Wegovy injection missed-dose, labeled weekly schedule, presentation-specific storage, and labeled injection pharmacokinetics (approximately 1-week half-life; present about 5 to 7 weeks after the last 2.4 mg or 7.2 mg injection). Tablet rules are not encoded.
- OZEMPIC (semaglutide) injection prescribing information
U.S. National Library of Medicine DailyMed / Novo Nordisk · Last verified 2026-09-16
Used for Ozempic missed-dose, labeled weekly schedule, pen/syringe storage, and labeled injection pharmacokinetics (approximately 1-week half-life; present about 5 weeks after the last dose; steady state after 4 to 5 weekly doses).
- ZEPBOUND (tirzepatide) injection prescribing information
U.S. National Library of Medicine DailyMed / Eli Lilly · Last verified 2026-09-16
Used for Zepbound missed-dose, labeled weekly schedule, presentation-specific storage, and labeled injection pharmacokinetics (approximately 5-to-6-day half-life; steady state after 4 weekly doses).
- MOUNJARO (tirzepatide) injection prescribing information
U.S. National Library of Medicine DailyMed / Eli Lilly · Last verified 2026-09-16
Used for Mounjaro missed-dose, labeled weekly schedule, presentation-specific storage, and labeled injection pharmacokinetics (approximately 5-day half-life; steady state after 4 weekly doses).
Related WellForm MD resources
Need individualized guidance?
These tools are free public education. WellForm MD also provides physician-led medical weight-loss care when you want a plan that belongs to you.
Book a free consultation